Frontiers in Immunology | Cancer Immunity and Immunotherapy

Editorial

Published on 24 Jun 2024

Editorial: The role of galectins in the immune microenvironment in human cancers and potential therapeutic approaches

in Cancer Immunity and Immunotherapy

Md Zahidul Islam Pranjol
Dmitry Aleksandrovich Zinovkin
Michael Petrovich Potapnev

Frontiers in Immunology

doi 10.3389/fimmu.2024.1448407

879 views

Original Research

Published on 24 Jun 2024

The effect of exercise and disease status on mobilization of anti-tumorigenic and pro-tumorigenic immune cells in women with breast cancer

in Cancer Immunity and Immunotherapy

Tiia Koivula
Salla Lempiäinen
Joona Neuvonen
Jooa Norha
Maija Hollmén
Carl Johan Sundberg
Helene Rundqvist
Heikki Minn
Petteri Rinne
Ilkka Heinonen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1394420

8,316 views
3 citations

Systematic Review

Published on 24 Jun 2024

Cardiovascular adverse events associated with immune checkpoint inhibitors: a meta-analysis

in Cancer Immunity and Immunotherapy

Xi Li
Dan Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1394123

2,458 views
2 citations

Original Research

Published on 24 Jun 2024

Decoding immune-related gene-signatures in colorectal neoplasia

in Cancer Immunity and Immunotherapy

Thura Akrem Omran
Hege Smith Tunsjø
David Jahanlu
Stephan Andreas Brackmann
Vahid Bemanian
Per Christian Sæther

Frontiers in Immunology

doi 10.3389/fimmu.2024.1407995

2,691 views
3 citations

Correction

Published on 24 Jun 2024

Corrigendum: Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies

in Cancer Immunity and Immunotherapy

Paul Noe
Joy H. Wang
Kyu Chung
Zhiyong Cheng
Jessica J. Field
Xiaomeng Shen
Stephanie C. Casey
Christa L. Cortesio
Cinthia V. Pastuskovas
Hyewon Phee

Frontiers in Immunology

doi 10.3389/fimmu.2024.1407085

997 views

Original Research

Published on 24 Jun 2024

A single-center, retrospective study-spring-evaluating the efficacy and safety of recombinant human vascular endothelial inhibitor combined with anti-PD-1 in elderly patients aged 80 and above with NSCLC

in Cancer Immunity and Immunotherapy

Tian Xing
Qianqian Gao
Hongbin Zhu
Jianrong Gao
Ganglin Yan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1402018

1,454 views

Original Research

Published on 24 Jun 2024

CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma

in Cancer Immunity and Immunotherapy

Michael W. Moles
Henry Erdlei
Lutz Menzel
Marialucia Massaro
Agnese Fiori
Mario Bunse
Moritz Schrimpf
Kerstin Gerlach
Venugopal Gudipati
John Reiser

Frontiers in Immunology

doi 10.3389/fimmu.2024.1383136

6,275 views
5 citations

Case Report

Published on 24 Jun 2024

Case report: Immunotherapy-based combination therapy achieving complete remission and prolonged survival in nasopharyngeal carcinoma with extensive bone marrow metastasis

in Cancer Immunity and Immunotherapy

Xingran Wang
Ying Yuan
Yan Zhang
Guanglei Qiao
Shihong Chen
Wentao Huang
Jianjun Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1410250

1,756 views
1 citation

Original Research

Published on 21 Jun 2024

Integrating single-cell and spatial transcriptomic analysis to unveil heterogeneity in high-grade serous ovarian cancer

in Cancer Immunity and Immunotherapy

Haixia Luo
Kunyu Wang
Bin Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1420847

4,146 views
2 citations

Original Research

Published on 21 Jun 2024

Real-world comprehensive genomic and immune profiling reveals distinct age- and sex-based genomic and immune landscapes in tumors of patients with non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Zachary D. Wallen
Heidi Ko
Mary K. Nesline
Stephanie B. Hastings
Kyle C. Strickland
Rebecca A. Previs
Shengle Zhang
Sarabjot Pabla
Jeffrey Conroy
Jennifer B. Jackson

Frontiers in Immunology

doi 10.3389/fimmu.2024.1413956

2,509 views
1 citation

Mini Review

Published on 20 Jun 2024

Single cell RNA-sequencing in uveal melanoma: advances in heterogeneity, tumor microenvironment and immunotherapy

in Cancer Immunity and Immunotherapy

Shiyi Tang
Yun Zhang
Shengmei Huang
Tengfei Zhu
Xiaojing Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1427348

3,361 views
2 citations

Original Research

Published on 20 Jun 2024

NAD metabolism-related genes provide prognostic value and potential therapeutic insights for acute myeloid leukemia

in Cancer Immunity and Immunotherapy

Yuncan Cao
Wenjing Shu
Peng Jin
Jianfeng Li
Hongming Zhu
Xinjie Chen
Yongmei Zhu
Xi Huang
Wenyan Cheng
Yang Shen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1417398

3,203 views

Systematic Review

Published on 20 Jun 2024

Prognostic relevance of prognostic nutritional indices in gastric or gastro-esophageal junction cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Shufu Hou
Dandan Song
Ruiqi Hao
Linchuan Li
Yun Zhang
Jiankang Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1382417

2,709 views
2 citations

Review

Published on 20 Jun 2024

The biological function of Serpinb9 and Serpinb9-based therapy

in Cancer Immunity and Immunotherapy

Haozhe Huang
Yiqing Mu
Song Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1422113

4,139 views
3 citations

Review

Published on 19 Jun 2024

Engineering strategies to safely drive CAR T-cells into the future

in Cancer Immunity and Immunotherapy

Matteo Rossi
Eytan Breman

Frontiers in Immunology

doi 10.3389/fimmu.2024.1411393

11,246 views
13 citations

Review

Published on 19 Jun 2024

Universal CAR 2.0 to overcome current limitations in CAR therapy

in Cancer Immunity and Immunotherapy

Lara Sophie Schlegel
Coralie Werbrouck
Michael Boettcher
Patrick Schlegel

Frontiers in Immunology

doi 10.3389/fimmu.2024.1383894

6,230 views
10 citations